333 related articles for article (PubMed ID: 36318353)
1. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives.
Han Y; Li L; Wang B
Front Med; 2022 Oct; 16(5):667-685. PubMed ID: 36318353
[TBL] [Abstract][Full Text] [Related]
2.
Han Y; Ling Q; Wu L; Wang X; Wang Z; Chen J; Zheng Z; Zhou Z; Jia L; Li L; Wang B
Gut Microbes; 2023; 15(1):2221485. PubMed ID: 37345844
[TBL] [Abstract][Full Text] [Related]
3.
Li T; Lin X; Shen B; Zhang W; Liu Y; Liu H; Wang Y; Zheng L; Zhi F
Front Immunol; 2022; 13():1047570. PubMed ID: 36531991
[TBL] [Abstract][Full Text] [Related]
4.
Banerjee G; Papri SR; Satapathy SK; Banerjee P
Curr Pharm Biotechnol; 2024; 25(4):426-433. PubMed ID: 37724669
[TBL] [Abstract][Full Text] [Related]
5. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Miura K; Ohnishi H
World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
7. Heat-Inactivated
Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
9. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
Qu D; Chen M; Zhu H; Liu X; Cui Y; Zhou W; Zhang M
Biochem Biophys Res Commun; 2023 Dec; 684():149131. PubMed ID: 37866242
[TBL] [Abstract][Full Text] [Related]
10. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
11. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Lee C; Kim J; Jung Y
Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
[TBL] [Abstract][Full Text] [Related]
12. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.
Su D; Nie Y; Zhu A; Chen Z; Wu P; Zhang L; Luo M; Sun Q; Cai L; Lai Y; Xiao Z; Duan Z; Zheng S; Wu G; Hu R; Tsukamoto H; Lugea A; Liu Z; Pandol SJ; Han YP
Front Physiol; 2016; 7():498. PubMed ID: 27895587
[TBL] [Abstract][Full Text] [Related]
14. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
15. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.
Chung KW; Cho YE; Kim SJ; Hwang S
Arch Pharm Res; 2022 Apr; 45(4):229-244. PubMed ID: 35391713
[TBL] [Abstract][Full Text] [Related]
16. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
17.
Jian H; Liu Y; Wang X; Dong X; Zou X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835309
[TBL] [Abstract][Full Text] [Related]
18. The Synbiotic Combination of
Juárez-Fernández M; Porras D; Petrov P; Román-Sagüillo S; García-Mediavilla MV; Soluyanova P; Martínez-Flórez S; González-Gallego J; Nistal E; Jover R; Sánchez-Campos S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943104
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
20. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.
Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y
Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]